Physician profile
Isaac Howley
NPI 1750605523
$1,794.28
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.60 · 2020: $1,175 · 2021: $138 · 2022: $233 · 2023: $213 · 2024: $15.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,568.24 | 2020-2023 | Advantagerib |
| Kerecis Limited | $94.88 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Baxter Healthcare | $33.16 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.82 | 2022 | |
| Integra Lifesciences Corporation | $21.11 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tetraphase Pharmaceuticals, INC. | $19.60 | 2019 | |
| Kci USA, INC. | $19.51 | 2023 | Prevena, V.A.C. Veraflo |
| Smith+Nephew, INC. | $15.96 | 2024 | Oasis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Howley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.